NBS05

Newborn Screening for Cystic Fibrosis, 2nd Edition

This guideline describes newborn screening laboratory tests for detecting analytes and genetic markers associated with cystic fibrosis (CF). It includes both the first-tier and second-tier screening tests performed on newborn dried blood spot specimens, as well as the screening strategies for identifying newborns at increased risk for developing CF.

Members: $54.00 → $153.00

Nonmembers: $180.00
Log in/sign up to see price and add to cart

Details

Chairholder: Debra Freedenberg, MD, PhD, FFACMG

Date of Publication: December 19, 2019

Order Code PDF: NBS05Ed2E
ISBN Number: 978-1-68440-065-2

Order Code Print: NBS05Ed2
ISBN Number: 978-1-68440-064-5

Edition: Second

Pages: 86

NBS05 Additional Details

A guideline for global application developed through the Clinical and Laboratory Standards Institute consensus process.

This document was formerly sold under the code ILA35.